Author: Edward Theodore Thompson
Publisher:
ISBN:
Category : National Conference on Medical Nomenclature (U.S.).
Languages : en
Pages : 648
Book Description
Textbook and Guide to the Standard Nomenclature of Diseases and Operations
Author: Edward Theodore Thompson
Publisher:
ISBN:
Category : National Conference on Medical Nomenclature (U.S.).
Languages : en
Pages : 648
Book Description
Publisher:
ISBN:
Category : National Conference on Medical Nomenclature (U.S.).
Languages : en
Pages : 648
Book Description
ICPC, International Classification of Primary Care
Author: Henk Lamberts
Publisher: Oxford University Press, USA
ISBN:
Category : Language Arts & Disciplines
Languages : en
Pages : 228
Book Description
Intended for family physicians and others in primary care delivery. Compatible with International classification of diseases, 9th ed.
Publisher: Oxford University Press, USA
ISBN:
Category : Language Arts & Disciplines
Languages : en
Pages : 228
Book Description
Intended for family physicians and others in primary care delivery. Compatible with International classification of diseases, 9th ed.
Definition of Serious and Complex Medical Conditions
Author: Institute of Medicine
Publisher: National Academies Press
ISBN: 0309172608
Category : Medical
Languages : en
Pages : 127
Book Description
In response to a request by the Health Care Financing Administration (HCFA), the Institute of Medicine proposed a study to examine definitions of serious or complex medical conditions and related issues. A seven-member committee was appointed to address these issues. Throughout the course of this study, the committee has been aware of the fact that the topic addressed by this report concerns one of the most critical issues confronting HCFA, health care plans and providers, and patients today. The Medicare+Choice regulations focus on the most vulnerable populations in need of medical care and other services-those with serious or complex medical conditions. Caring for these highly vulnerable populations poses a number of challenges. The committee believes, however, that the current state of clinical and research literature does not adequately address all of the challenges and issues relevant to the identification and care of these patients.
Publisher: National Academies Press
ISBN: 0309172608
Category : Medical
Languages : en
Pages : 127
Book Description
In response to a request by the Health Care Financing Administration (HCFA), the Institute of Medicine proposed a study to examine definitions of serious or complex medical conditions and related issues. A seven-member committee was appointed to address these issues. Throughout the course of this study, the committee has been aware of the fact that the topic addressed by this report concerns one of the most critical issues confronting HCFA, health care plans and providers, and patients today. The Medicare+Choice regulations focus on the most vulnerable populations in need of medical care and other services-those with serious or complex medical conditions. Caring for these highly vulnerable populations poses a number of challenges. The committee believes, however, that the current state of clinical and research literature does not adequately address all of the challenges and issues relevant to the identification and care of these patients.
Standard Nomenclature of Diseases and Pathological Conditions, Injuries, and Poisonings for the United States
Author: United States. Bureau of the Census
Publisher:
ISBN:
Category : Diseases
Languages : en
Pages : 356
Book Description
Publisher:
ISBN:
Category : Diseases
Languages : en
Pages : 356
Book Description
WHO Classification of Skin Tumours
Author: Centre international de recherche sur le cancer
Publisher: International Agency for Research on Cancer
ISBN: 9789283224402
Category : Medical
Languages : en
Pages : 0
Book Description
The WHO Classification of Skin Tumours is the 11th volume in the 4th edition of the WHO series on the classification of human tumours. The series (also known as the Blue Books) has long been regarded by pathologists as the gold standard for the diagnosis of tumours, and it is an indispensable guide for the design of evaluations, clinical trials, and studies involving cancer. These authoritative and concise reference books provide an international standard for anyone involved in cancer research or the care of cancer patients. Diagnostic criteria, pathological features, and genetic and other associated molecular alterations are described in a disease-oriented manner. This volume updates the existing ICD-O codes and provides new codes for use in epidemiology and cancer registration. It also provides information on clinical features, pathology, genetics, prognosis, and protective factors for each of the tumour types covered. The editors expect that this volume will be of particular interest to pathologists, oncologists, and dermatologists who manage or research skin tumours. Sections are included on all recognized neoplasms (and their variants) of the skin and its adnexae. Since the previous edition, there have been particularly substantial changes to the classification of melanoma, based on the latest information from genetic and molecular studies.
Publisher: International Agency for Research on Cancer
ISBN: 9789283224402
Category : Medical
Languages : en
Pages : 0
Book Description
The WHO Classification of Skin Tumours is the 11th volume in the 4th edition of the WHO series on the classification of human tumours. The series (also known as the Blue Books) has long been regarded by pathologists as the gold standard for the diagnosis of tumours, and it is an indispensable guide for the design of evaluations, clinical trials, and studies involving cancer. These authoritative and concise reference books provide an international standard for anyone involved in cancer research or the care of cancer patients. Diagnostic criteria, pathological features, and genetic and other associated molecular alterations are described in a disease-oriented manner. This volume updates the existing ICD-O codes and provides new codes for use in epidemiology and cancer registration. It also provides information on clinical features, pathology, genetics, prognosis, and protective factors for each of the tumour types covered. The editors expect that this volume will be of particular interest to pathologists, oncologists, and dermatologists who manage or research skin tumours. Sections are included on all recognized neoplasms (and their variants) of the skin and its adnexae. Since the previous edition, there have been particularly substantial changes to the classification of melanoma, based on the latest information from genetic and molecular studies.
WHO Classification of Tumours. Digestive System Tumours
Author:
Publisher: International Agency for Research on Cancer
ISBN: 9789283244998
Category : Medical
Languages : en
Pages : 0
Book Description
Digestive System Tumours is the first volume in the fifth edition of the WHO series on the classification of human tumors. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education.
Publisher: International Agency for Research on Cancer
ISBN: 9789283244998
Category : Medical
Languages : en
Pages : 0
Book Description
Digestive System Tumours is the first volume in the fifth edition of the WHO series on the classification of human tumors. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumors and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education.
A Standard Nomenclature of Veterinary Diseases and Operations
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Animals
Languages : en
Pages : 572
Book Description
Publisher:
ISBN:
Category : Animals
Languages : en
Pages : 572
Book Description
WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Disease
Author: World Small Animal Veterinary Association. Liver Standardization Group
Publisher: Elsevier Health Sciences
ISBN: 070202791X
Category : Cats
Languages : en
Pages : 143
Book Description
This volume describes guidelines for diagnosis of liver diseases in dogs and cats, using both histological and clinical criteria. All diseases and their variations are illustrated by images of the macroscopic and histopathological features, alongside theessential criteria which are required for diagnosis.
Publisher: Elsevier Health Sciences
ISBN: 070202791X
Category : Cats
Languages : en
Pages : 143
Book Description
This volume describes guidelines for diagnosis of liver diseases in dogs and cats, using both histological and clinical criteria. All diseases and their variations are illustrated by images of the macroscopic and histopathological features, alongside theessential criteria which are required for diagnosis.
Standard Nomenclature of Veterinary Diseases and Operations
Author: National Cancer Institute (U.S.)
Publisher:
ISBN:
Category : Domestic animals
Languages : en
Pages : 196
Book Description
Publisher:
ISBN:
Category : Domestic animals
Languages : en
Pages : 196
Book Description
The Prevention and Treatment of Missing Data in Clinical Trials
Author: National Research Council
Publisher: National Academies Press
ISBN: 030918651X
Category : Medical
Languages : en
Pages : 163
Book Description
Randomized clinical trials are the primary tool for evaluating new medical interventions. Randomization provides for a fair comparison between treatment and control groups, balancing out, on average, distributions of known and unknown factors among the participants. Unfortunately, these studies often lack a substantial percentage of data. This missing data reduces the benefit provided by the randomization and introduces potential biases in the comparison of the treatment groups. Missing data can arise for a variety of reasons, including the inability or unwillingness of participants to meet appointments for evaluation. And in some studies, some or all of data collection ceases when participants discontinue study treatment. Existing guidelines for the design and conduct of clinical trials, and the analysis of the resulting data, provide only limited advice on how to handle missing data. Thus, approaches to the analysis of data with an appreciable amount of missing values tend to be ad hoc and variable. The Prevention and Treatment of Missing Data in Clinical Trials concludes that a more principled approach to design and analysis in the presence of missing data is both needed and possible. Such an approach needs to focus on two critical elements: (1) careful design and conduct to limit the amount and impact of missing data and (2) analysis that makes full use of information on all randomized participants and is based on careful attention to the assumptions about the nature of the missing data underlying estimates of treatment effects. In addition to the highest priority recommendations, the book offers more detailed recommendations on the conduct of clinical trials and techniques for analysis of trial data.
Publisher: National Academies Press
ISBN: 030918651X
Category : Medical
Languages : en
Pages : 163
Book Description
Randomized clinical trials are the primary tool for evaluating new medical interventions. Randomization provides for a fair comparison between treatment and control groups, balancing out, on average, distributions of known and unknown factors among the participants. Unfortunately, these studies often lack a substantial percentage of data. This missing data reduces the benefit provided by the randomization and introduces potential biases in the comparison of the treatment groups. Missing data can arise for a variety of reasons, including the inability or unwillingness of participants to meet appointments for evaluation. And in some studies, some or all of data collection ceases when participants discontinue study treatment. Existing guidelines for the design and conduct of clinical trials, and the analysis of the resulting data, provide only limited advice on how to handle missing data. Thus, approaches to the analysis of data with an appreciable amount of missing values tend to be ad hoc and variable. The Prevention and Treatment of Missing Data in Clinical Trials concludes that a more principled approach to design and analysis in the presence of missing data is both needed and possible. Such an approach needs to focus on two critical elements: (1) careful design and conduct to limit the amount and impact of missing data and (2) analysis that makes full use of information on all randomized participants and is based on careful attention to the assumptions about the nature of the missing data underlying estimates of treatment effects. In addition to the highest priority recommendations, the book offers more detailed recommendations on the conduct of clinical trials and techniques for analysis of trial data.